Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales

BACKGROUND: The Cancer Drugs Fund (CDF) provides £200 million annually in England for ‘anti-cancer' drugs. METHODS: We used a controlled pre-/post-intervention design to compare IMS Health dispensing data for 15 cancer drugs (2007–2012) in England vs Wales, stratified by pre-CDF NICE drug appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamberlain, C, Collin, S M, Stephens, P, Donovan, J, Bahl, A, Hollingworth, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453744/
https://www.ncbi.nlm.nih.gov/pubmed/24569469
http://dx.doi.org/10.1038/bjc.2014.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453744/
https://www.ncbi.nlm.nih.gov/pubmed/24569469
http://dx.doi.org/10.1038/bjc.2014.86

Ejemplares similares